Company News

Divine Skin Granted DEA License

Firm is working on new OTC analgesic

Divine Skin has been granted a Drug Enforcement Agency license in partnership with its manufacturing partner to produce and distribute Ephedrine containing drugs and other controlled substances.



The company has started working on a new OTC analgesic, which it believes could provide an alternative to current OTC pain relievers. Receiving this mandatory license is the final step in commencing manufacturing of its OTC pain reliever, according to the firm, which is based in Miami Beach, FL.

Add us as a preferred source on Google

Get the latest Happi news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Happi Newsletters